Sfoglia per AUTORE
AVOLA R
Collezione ASL Torino 3

  

Items : 1

Phase II, noncomparative, open label, multicenter, study of osimertinib, in patients with locally advanced or metastatic EGFR mutated, T790M undetectable or unknown non-small cell lung cancer (Stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study) in Journal of Clinical Oncology

2021
ASL Torino 3

Soto Parra HJ; Noto L; Verderame F; Galetta D; Barbieri V; Ferrau F; Migliorino MR; Catino A; Aiello MM; Capelletto E; Ricciardi S; Spinnato F; Tassone P; Morelli AM; Latteri F; Gozzo L; Valerio O; Avola R; Novello S;